Author:
Wiedmann Timothy S.,Wattenberg Lee W.
Reference62 articles.
1. Sharma S, White D, Imondi AR, et al. Development of inhalational agents for oncologic use. J Clin Oncol 2001;19:1839–1847.
2. Edsbacker S. Uptake, retention, and biotransformation of corticosteroids in the lung and airways. Schleimer RP, O’Byrne PM, Szefler SJ, Brattsand R, eds. in: Inhaled Steroids in Asthma: Marcel Dekker, Inc., New York, 2002, pp. 213–246.
3. Everard ML. Aerosol therapy past, present, and future: a clinician’s perspective. Respir Care 2000;45:769–776.
4. Hickey AJ, Garcia-Contreras L. Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans. Crit Rev Ther Drug Carrier Syst 2001;18:387–431.
5. Gonda I. The ascent of pulmonary drug delivery. J Pharm Sci 2000;89:940–945.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Image-guided drug delivery in lung cancer;Drug Delivery and Translational Research;2012-01-11
2. Inhalation Adjuvant Therapy for Lung Cancer;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2010-08